Get Started

LUCD

NASD Lucid Diagnostics Inc.
Oct 28, 2026 · 4:58 AM ET LAST TRADE Market Closed

$0.4290 ↓ -0.0091 (-2.08%) Trading Down from the previous close of $0.4381

YTD change
-60.64%
vs 20-day SMA
-19.08%
vs 200-day SMA
-58.58%

Price ranges

Previous day
$0.4150 $0.5456
open $0.5200 close $0.4381
-$0.0819 (-15.75%)
Today
$0.0000 $0.0000
$0.4290
Past week
$0.3030 $0.5600
from $0.3519 now $0.4290
+$0.0771 (+21.91%)
Past month
$0.3030 $0.8152
from $0.8090 now $0.4290
-$0.3800 (-46.97%)
This year
$0.3030 $1.6293
from $1.0900 now $0.4290
-$0.6610 (-60.64%)

Price & Performance

-0.60 (-57.88%) / 6M

$0.2619$0.5799$0.8978$1.22Apr 28Jul 29Oct 27

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 96.8% away from all-time highs of $13.5200
  • LUCD is down 61% since the beginning of the year
  • LUCD is down 66% over the past 12 months
  • LUCD is down 47% over the past 1 month
  • 8% of all LUCD investors are betting against LUCD

LUCD reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -65.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.06
Earnings momentum -4.3% Quarterly EPS growth
Quarterly change -4.3%

Valuation

P/E ratio N/A
Enterprise value $83.2M
Beta -0.29

Balance sheet & scale

IncomeN/A
Revenue$5.4M
Cash$33.4M
Debt$24.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap $87.2M

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CDR CAD HEDGED $34.25 +0.82%
BDX Becton, Dickinson and Company $195.03 -0.69%
DXCM DexCom, Inc. $78.56 -0.01%
MDLN Medline, Inc. Class A $32.38 -3.89%
WST West Pharmaceutical Services, Inc. $398.29 +0.90%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.